HR | 95% CI | p Value | |
---|---|---|---|
Primary prevention versus no ICD | 0.40 | 0.19 to 0.85 | 0.016 |
Secondary prevention versus no ICD | 0.48 | 0.26 to 0.89 | 0.019 |
CRT-D versus ICD | 0.76 | 0.45 to 1.29 | 0.31 |
Age (>60 years vs <60 years) | 1.21 | 0.87 to 1.68 | 0.27 |
Male | 0.63 | 0.43 to 0.92 | 0.02 |
Ischaemic cardiomyopathy | 0.76 | 0.52 to 1.1 | 0.15 |
Atrial fibrillation versus sinus rhythm | 1.51 | 0.99 to 2.29 | 0.05 |
β-Blocker | 0.80 | 0.59 to 1.09 | 0.17 |
Spironolactone | 0.96 | 0.72 to 1.27 | 0.78 |
Amiodarone | 1.15 | 0.75 to 1.76 | 0.52 |
NYHA class III versus NYHA II | 1.79 | 0.78 to 4.1 | 0.17 |
NYHA class IV versus NYHA II | 2.28 | 0.98 to 5.34 | 0.06 |
EF (>20% vs <20%) | 0.83 | 0.62 to 1.09 | 0.18 |
Year of listing for transplantation (per year) | 1.02 | 0.98 to 1.06 | 0.37 |
HRs and 95% CIs are presented.
CRT-D, cardiac resynchronisation therapy plus defibrillator; EF, ejection fraction; ICD, implantable cardioverter defibrillator; NYHA, New York Heart Association.